We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Shares in drug maker Dr. Reddy's Laboratories Ltd. jumped as much as 18.5 per cent on Tuesday, after a U.S. court ruling in favour of a rival on a generic cholesterol drug was seen to benefit the Indian firm too.
The government of Ethiopia has launched a five-year, $447 million malaria treatment and prevention plan. Malaria is one of the leading causes of illness and death in the country, according to the country's Ministry of Health has reported.
Chemotherapy combined with etanercept, a drug typically used to treat rheumatoid arthritis may help reduce the fatigue and muscle-wasting that often afflicts cancer patients, according to research published in the Journal of Clinical Oncology.
The European Committee for Medicinal Products for Human Use (CHMP) has granted Bayer and Onyx Pharmaceuticals a positive opinion for Nexavar (sorafenib) — a treatment for patients with advanced renal cell carcinoma (RCC) who have failed prior interferon-alpha or interleukin-2 based therapy.
Japanese drugmaker Chugai has announced that the recombinant human erythropoietin Epogin (epoetin beta-recombinant), an injectable medication currently marketed for renal anemia in adults, has obtained an additional effect-efficacy for anemia in premature infants.
Zonagen, Inc. today reported financial results for the first quarter ended March 31, 2006; announced its 2006 Annual Meeting of Stockholders to be held in New York City on May 2, 2006; and provided an update on clinical development programs.
Company AlphaRx Inc., an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, announced today that its wholly owned subsidiary, AlphaRx International Holdings Limited ("AIH"), has entered into a Joint Venture Agreement, ("JV") with a leading Chinese marketing company (the "China Party"), to establish a Joint Venture Company, ("JV Company") in China, for the purpose of manufacturing, marketing and distributing AIH's proprietary line of pharmaceutical and consumer health (over-the-counter) products in Asia.
U.S. Bank has provided the financing to help develop apotentially life-saving therapeutic for non-Hodgkin's lymphoma,marking the first time the New Market Tax Credit (NMTC) program hasbeen used to support a biopharmaceutical
company.